Fidson, which is listed in Lagos where its stock has shed 24.6 per cent this year, is valued at N30.3 billion.
The post Fidson's drug manufacturing pact with Chinese firms raises hope for Nigeria's HIV patients appeared first on Premium Times Nigeria.
